rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

POMDOCTOR LIMITED - Class A

POM · Nasdaq

Consumer DiscretionaryRetail — SpecialtyNot moving yet

POM stood above a rising 150-day average in 0 of the last 20 weekly readings. It is 50.1% below that average now. Retail — Specialty: 25% of its 106 stocks in an uptrend (−4 points in four weeks); Consumer Discretionary: 25% (−0 points in four weeks).

Statistics

Last close, 23 Oct 2026
1.17 −42.36%
52-week range
—
Volume
4.61M
Average volume (50 days)
—
Relative volume
—
Rotation
Not moving yet
Weeks in an uptrend
out for 20
Industry in uptrend
25% -4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
6 (-3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 20 weeks.

24 Apr – 23 Oct
21%30%38%Apr 26Jun 26Jul 26Sep 26Oct 26

Retail — Specialty: A minority of its stocks are in an uptrend and the share has been slipping. Consumer Discretionary: A minority of its stocks are in an uptrend and the share has held steady.

Price and volume

$0.5261$1.78$3.0311 Sep23 Sep5 Oct14 Oct23 Oct
close

Daily bars to 23 Oct 2026: 30 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders6-3 on the quarter
New · exited1 · 4
Reported value$38K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCreduced · filed 14 Aug 202621,273$31K-343,330−94.2%
UBS Group AGreduced · filed 13 Aug 20263,463$5,021-13,180−79.2%
Caitong International Asset Management Co., Ltdreduced · filed 5 Aug 2026893$1,295-30,692−97.2%
Arax Advisory Partnersnew · filed 10 Aug 2026722$1,047+722
Steward Partners Investment Advisory, LLCreduced · filed 13 Aug 2026111$161-1,889−94.4%
RHUMBLINE ADVISERSreduced · filed 12 Aug 202641$60-709−94.5%
31 Dec 2025 – 30 Jun 2026
689Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202513.1%
Operating profit marginFY 2025 · to 31 Dec 2025-29.7%
Free cash flow marginFY 2025 · to 31 Dec 2025-37.4%
Interest coverFY 2025 · to 31 Dec 2025-30.11×
Research spendFY 2025 · to 31 Dec 20253.2%
Revenue growthFY 2025 · to 31 Dec 202412.4%
Share count trendFY 2025 · to 31 Dec 20240.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.4M
Free cash flowFY 2025 · to 31 Dec 2025−$21.4M

Analyst forecasts

No analyst forecasts yet.